RecruitingNot ApplicableNCT06376565

Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps

Multilevel Health System Intervention to Increase Guideline-Concordant Surveillance Colonoscopy for High Risk Colon Polyps

Sponsor

Jonsson Comprehensive Cancer Center

Enrollment

1,680 participants

Start Date

Nov 8, 2023

Study Type

INTERVENTIONAL

Conditions

Colorectal Carcinoma

Summary

This clinical trial tests a multilevel intervention at the clinic, provider and patient levels, to improve colonoscopy surveillance in patients with high risk colon polyps. Colorectal cancer (CRC) is a common and deadly disease that is largely preventable through the detection and removal of colorectal polyps. One million Americans are diagnosed with high risk polyps of the colon or rectum annually and are at increased risk for CRC; however, uptake of recommended repeat colonoscopy in 3 years to reduce CRC risk is low in this group. This multilevel intervention may work to improve timely colonoscopy screening for patients with high risk colon polyps.

Eligibility

Min Age: 21 Years

Inclusion Criteria5

AIM 1 PATIENTS: Patients between age 45 and 75 with a HRN diagnosis in the past 5 years
AIM 1 PATIENTS: 12 patients who did and 12 patients who did not have surveillance colonoscopy
AIM 1 PROVIDERS: Primary care providers (PCPs) and gastroenterologists (GIs)
AIM 1 ADMINISTRATORS: Administrators who are involved in care processes related to CRC screening, HRN surveillance, and/or colonoscopy scheduling
AIM 2: Patients age 45 to 75 diagnosed with a HRN during the pre-specified two-year HRN diagnosis period

Exclusion Criteria2

AIM 2: Individuals with a personal history of colorectal carcinoma (CRC), inflammatory bowel disease (Crohn's, ulcerative colitis), or polyposis syndrome
AIM 2: HRN cases not confirmed by chart review (human-in-the-loop)